 Management TeamDr. Mike Asbury The non-executive Chairman Mike Asbury, is medically qualified and has held numerous general management and marketing positions in the pharmaceutical industry since the early 1980's. Mike was the International Marketing Director at Zeneca Pharmaceuticals and Vice-President of Global Licensing at AstraZeneca. He has extensive knowledge of the development and marketing of ethical pharmaceuticals and all forms of deal-making in the pharmaceutical industry. John Lyon The CEO, John Lyon, has a track record in growing commercial life science businesses and in particular, strong experience in managing the drug development process. John Lyon held the position of Global Vice President within a publicly quoted NYSE Company and was the Managing Director of their world renowned clinic in Leeds, UK, through which many approved medicines have been developed. John Lyon is a Fellow of the Institute of Chartered Accountants (Price Waterhouse), a Fellow of the Securities Institute, a Fellow of the Institute of Clinical Research and a qualified Clinical Biochemist, having trained at St George's Hospital and St Mary's Hospital in London. Prof. Stanley Brown The CSO, Stan Brown, is also the Chair of Biochemistry and Director of the Centre of Photobiology and Photodynamic Therapy at the University of Leeds, UK. Stan is one of the global leaders in PDT and has published around 200 research papers and four books. He has given many invited lectures on PDT in oncology and antimicrobial therapy around the world. Stan was Pro-Vice Chancellor of the University of Leeds 1993-96, President of the European Society for Photobiology 1999-2001 and a non-executive director of Yorkshire Regional Health Authority. Dr. Nicola Broughton The Commercial Director, Nicola Broughton, was the business manager at Leeds Innovations, the University of Leeds technology transfer company, prior to joining Photopharmica. Nicola has a life science background with a PhD in molecular biology and cancer research and an MBA. Nicola specialises in spin-out companies, patenting and licensing. Prof. John Griffiths Director of Chemistry for Photopharmica and Professor of Functional Dye Chemistry at the University of Leeds, John Griffiths oversees the synthesis and chemical characterisation of Photopharmica's new drugs. He has many years experience in dye chemistry and organic photochemistry, and has published 2 books and more than 150 research papers and patents in these fields. Dr. Kirste Mellish Senior Programme Manager, Kirste Mellish is a biochemist with a PhD and postdoctoral experience in the discovery and development of novel anticancer drugs, both for chemotherapy and photodynamic therapy. Kirste was a research fellow in the Centre for Photobiology and Photodynamic Therapy at the University of Leeds for a number of years prior to joining Photopharmica. Lucy Sharpson The Office Manager, Lucy Sharpson, coordinates, develops and delivers the range of support services utilised within the office. As the Company's Health and Safety Officer she is also responsible for compliance with Health and Safety Regulations and ensures a safe working environment for all employees. Lucy has extensive office management experience and previously held positions at other companies as a PA and Team Support Officer. Rachel Johnston Programme Associate, Rachel Johnston has a first class Honours Degree in Biochemistry. Rachel completed her final year project within the Photodynamic Therapy Laboratories at Leeds University, where she carried out preliminary research on one of Photopharmica’s drug candidates. Dr. Clare Conway Programme Manager, Clare Conway studied BSc Biomedical Sciences at the University of Bradford and graduated with First Class Honours. Clare also has a PhD in anti-cancer photodynamic therapy which was undertaken in the Centre of Photobiology and Photodynamic Therapy at the University of Leeds. ^ top |
